Lipo Hydroxy Acid

PreclinicalSmall molecule

CCosmetique Active International

Lipo Hydroxy Acid is one of 6 small molecule programs targeting Acne Vulgaris. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Acne VulgarisCompleted

Acne VulgarisPreclinical

Completed

Competition

Competitive Landscape

5 competitors in Acne Vulgaris

#DrugCompanyPhaseTrials

Experimental Drug

MMedesis Pharma SA

Phase 3

1 2

Aklief

GGalderma R&D

Phase 3

2 3

Secretome

BBaermed

Phase 2

1 4

N-Acetyl-GED-0507-34-Levo

PPPM Services S.A.

Phase 3

3 5

Dihydroartemisinin

KKunming Pharmaceuticals, Inc.

Phase 1

1 6

Lipo Hydroxy Acid

CCosmetique Active International

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Acne Vulgaris1 trial

Efficacy and Tolerance of a Derivative of Salicylic Acid and 5% Benzoyl Peroxide in Facial Acne Vulgaris

Completed·CCosmetique Active International·N/A·NCT00624676·80 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for Lipo Hydroxy Acid. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Lipo Hydroxy Acid compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Lipo Hydroxy Acid. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Cosmetique Active International company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: CCosmetique Active International

Lipo Hydroxy Acid

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Acne Vulgaris1 trial

References

Drug Info

Quick Facts

Related News